Polypeptide
Malmö, Sweden polypeptide.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
PolyPeptide is a peptide CDMO that develops and manufactures peptide active pharmaceutical ingredients for pharmaceutical and biotech customers worldwide. It supports projects from pre-GMP development and clinical trials through commercial manufacturing, with facilities in Europe, the US, and India.
Services
Pre-GMP development
Develops robust production approaches, analytical characterization, and pilot or pre-GMP toxicology lots before GMP manufacture.
GMP peptide manufacturing
Manufactures GMP-grade peptides from initial gram quantities through commercial multi-kilogram batch requirements.
Production
Develops and scales small- to large-scale production processes for proprietary and generic peptides, including complex peptides.
Quality assurance
Releases product after batch record review and verifies compliance with cGMP requirements.
Quality control
Performs analytical development and GMP testing procedures to support API release for clinical and commercial material.
Regulatory support
Prepares regulatory documentation and supports interactions with health authorities for IND/IMPD, NDA/MAA, DMFs/ASMFs, and CEPs.
Commercial manufacturing
Manufactures commercial peptide APIs and supports approval and commercialization activities.
Process development and optimization
Selects synthesis routes and optimizes manufacturing processes across the product life cycle, including clinical and commercial stages.
7 more services
- Capacity and capabilities
- Custom R&D
- Custom research grade peptides
- Radiolabeled peptide production
- Generic peptides
- GMP Compliance
- Radiolabeled peptide
- What to send
- Clients can request a quote
- Manufacturing support for physician sponsored IND, corporate IND, and commercial manufacturing
- Sequence
- Composition
- Project requirements
Capabilities
As they state on their website or in their listing.
- Processes
- Peptide API manufacturing
- Pre-GMP development
- Analytical characterization
- Pilot lots
- Pre-GMP animal toxicology lots
- Small-scale production
11 more
- Large-scale production
- Solution phase peptide manufacturing
- Solid phase peptide manufacturing
- Hybrid peptide manufacturing
- Quality assurance review
- Quality control testing
- Regulatory support
- Peptides
- Process development
- Peptide synthesis
- Toxicology
- Capacity
- From initial gram quantities to multi-kilograms or more per batch
- Lot sizes typically up to 1 kg
- Up to 6,300L reactor size
- Metric tons
- 6 sites on 3 continents
- Initial gram quantities
3 more
- Multi-kilograms or more per batch
- Mg quantities
- Around one half of the approved peptide APIs in the world
- Offers
- Custom synthesis
- Scales
- Milligram · Gram · Kilogram
Equipment
- Solid phase synthesis units
- Intermediary processing laboratories
- Purification suites
- Lyophilizers
- Reactors up to 200L
- Reactors up to 650L
- Reactor size up to 6,300L
Materials
- Peptide active pharmaceutical ingredients
- GMP grade peptides
- cGMP
- ICH guidelines
- Q7
- Acetate
- Trifluoroacetic acid
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 14001Self-reported
Scope: Malmö site certification
GMPSelf-reported
Scope: quality assurance and quality control
Company
- Type
- CDMO
- Founded
- 1952
- Size
- 1001-5000 employees
- Ownership
- Small business, as registered with SAM.gov or stated on their site
Locations
- Office
- 365 Maple Avenue Torrance CA 90503 USA
- Sites
- Baar, Switzerland
- Limhamn, Sweden
- Strasbourg, France
- Braine-l’Alleud, Belgium
- Torrance, USA
- San Diego, USA
- Ambernath, India
- Serves
- North America, Europe, Asia, worldwide, around the globe
Public records
- Biocom California CRO directory
- neoantigen, Peptides, small molecule source